Trytosaveabit commented on a stock · Nov 9, 2023 06:32

Update

$BridgeBio Pharma(BBIO.US)$ BridgeBio Pharma to Present Additional Data from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the American Heart Association (AHA) Scientific Sessions 2023
2 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

11K Views

Comment

Trytosaveabit

1740Followers

28Following

20KVisitors